Pharmaceutical cluster

CREATION OF NEW WORKPLACES
CREATION OF NEW
WORKPLACES
Icon
IMPROVING SCIENCE
AND TECHNOLOGY
INFRASTRUCTURE
Icon
IMPORT SUBSTITUTION
OF PHARMACEUTICAL
PRODUCTS
Icon
DEVELOPMENT
OF PHARMACEUTICS,
CREATION OF INNOVATIVE
PRODUCTS
Icon
DEVELOPMENT
OF THE REGIONAL
INFRASTRUCTURE
AROUND THE CLUSTER
Factors of formation and enhancement
of the pharmaceutical cluster in the Kaliningrad Region
  • Progressive legislation of the SEZ
  • Competitive benefits and preferences
  • Favorable geographic location
  • Availability of the necessary institutions
  • Support of federal and local authorities
  • Low level of social tension in the region
  • Low level of pollution
  • High level of development and accessibility of infrastructure
  • High financial sustainability of the regional budget
  • Robust construction industry in the region
  • Excellent export opportunities
  • Opportunities for foreign specialists
  • Geographical proximity of the pharmaceutical production centers with a large number of skilled professionals (Belarus, Baltics, Poland)
Picture

RESIDENTIAL POLICY OF THE PARK

(requirements for potential investors):
  • Projects in the field of pharmacy and medical product manufacturing have priority. Other projects may also be considered in case of limited impact on the environment (productions of V, IV and III class of hazard, with the sanitary protection zone no more than 300 m)
  • The relations between the management company and residents of the industrial park are defined by an agreement on production and industrial activities on the territory of the ECOBALTIC industrial park

Pharmaceutical plant INFAMED K

Pharmaceutical plant INFAMED K
Pharmaceutical plant INFAMED K
The key resident of the park is a Russian pharmaceutical company, an exclusive manufacturer of an innovative popular antiseptic product Miramistin® and Okomistin® eye drops, with the production output of up to 100 mln units a year